Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The FDA and FTC one-two punch should dent sales, but as the stem cell wild west has proven, that may not stop sales
Disclosure first PeptideBenchmark has a disclosed referral relationship with InfiniWell and may earn compensation from qualifying purchases
Although BPC-157 has been proven safe and well-tolerated in clinical trials, there are potential risks such as allergic reactions, interactions with other medications, and unknown long-term effects
Carcinogenesis, Mutagenesis, Impairment of Fertility Long term studies in animals to evaluate carcinogenic potential have not been done
GHK-CU has been studied for its antioxidant-related activity and role in supporting cellular communication and overall skin vitality
Importantly, inclusion on the 503A pathway would not represent FDA approval or confirmation of clinical efficacy, but rather a regulatory mechanism allowing compounding under specific conditions
